ABT vs CDNA · P/E 25, rev $44.33B vs rev $333.8M
Abbott Laboratories (ABT) versus CareDx Inc (CDNA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CDNA currently screens at market cap $1.18B.
Not investment advice. Open the ABT and CDNA stock pages for the full models.
Not investment advice.